How it works.
Retatrutide is a synthetic peptide that engages three glucose- and energy-regulating pathways from a single molecule: the GIP, GLP-1, and glucagon receptors. The added glucagon-receptor arm is the distinguishing feature — in published animal and clinical research it contributes to increased energy expenditure and hepatic lipid handling beyond what dual GIP/GLP-1 agonism produces. A C20 fatty-diacid moiety promotes albumin binding, extending plasma half-life to a once-weekly profile.
Verified buyer notes.
Initials only — every quote is verified against an order record. We don’t ghost-write reviews.
“COA matched what we ran in-house. Powder reconstituted clean, no haze. Did exactly what we needed it to.”
“Switched after two bad lots from a previous source. Three orders in, zero issues.”
“Shipment got delayed two days by weather and still arrived at 4°C. Packaging is no joke.”
The shared signature.
04Coming soonA dual GIP/GLP-1 receptor agonist studied for its effects on glycemic regulation and adipose tissue metabolism.
04Coming soonA long-acting GLP-1 receptor agonist studied for its effects on glycemic control, satiety signaling, and adipose tissue.
04Coming soonA long-acting amylin analog studied as an adjunct to GLP-1 agonism in metabolic research.
04Coming soonA 16-amino-acid fragment of human growth hormone studied for its effects on lipolysis without GH receptor activity.